Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03290 | 34058299 | Diabetes Res Clin Pract | Current type 2 diabetes, rather than previous gestational diabetes, is associated with liver disease in U.S. Women. | 2021 | Details |
| A03295 | 34057682 | Cell Mol Neurobiol | The Role of Epigenomic Regulatory Pathways in the Gut-Brain Axis and Visceral Hyperalgesia. | 2021 | Details |
| A03303 | 34051282 | Diabetes Res Clin Pract | Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease. | 2021 | Details |
| A03304 | 34051210 | Biochem Pharmacol | The controversy on the beneficial effect of phytoestrogens in diabetic treatment in postmenopausal women. | 2021 | Details |
| A03310 | 34049870 | BMJ Open Diabetes Res Care | Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes. | 2021 | Details |
| A03321 | 34046015 | Front Endocrinol (Lausanne) | Epigenetics of Hepatic Insulin Resistance. | 2021 | Details |
| A03326 | 34043630 | PLoS One | Association between toothbrushing and non-alcoholic fatty liver disease. | 2021 | Details |
| A03328 | 34043368 | J Proteome Res | Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients. | 2021 | Details |
| A03332 | 34040583 | Front Endocrinol (Lausanne) | Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. | 2021 | Details |
| A03334 | 34040322 | World J Gastroenterol | Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. | 2021 | Details |
| A03339 | 34036255 | JHEP Rep | Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past. | 2021 | Details |
| A03348 | 34032730 | Medicine (Baltimore) | Acupuncture for type 2 diabetes mellitus with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2021 | Details |
| A03354 | 34031327 | Med J Malaysia | Liver fibrosis associated with adipose tissue and liver inflammation in an obesity model. | 2021 | Details |
| A03355 | 34031143 | Diabetes Care | The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes. | 2021 | Details |
| A03357 | 34029949 | Biomed Pharmacother | The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine model. | 2021 | Details |
| A03359 | 34028830 | Med J Aust | Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study. | 2021 | Details |
| A03361 | 34027933 | Minerva Gastroenterol (Torino) | The role of elastography in non-alcoholic fatty liver disease. | 2021 | Details |
| A03370 | 34027265 | Hepatol Commun | Impact of Sodium Glucose Cotransporter 2 Inhibitors on Nonalcoholic Fatty Liver Disease Complicated by Diabetes Mellitus. | 2021 | Details |
| A03374 | 34026086 | Food Sci Nutr | Alpha-lipoic acid alleviates NAFLD and triglyceride accumulation in liver via modulating hepatic NLRP3 inflammasome activation pathway in type 2 diabetic rats. | 2021 | Details |
| A03376 | 34025577 | Front Endocrinol (Lausanne) | Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII. | 2021 | Details |
| A03393 | 34017413 | Am J Transl Res | Correlation of CD3+/CD4+, and serum CK-18 fragment levels with glucose and lipid metabolism in elderly type 2 diabetes patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A03398 | 34016738 | J Investig Med | Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease. | 2021 | Details |
| A03400 | 34015596 | Int Immunopharmacol | Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies. | 2021 | Details |
| A03422 | 34006273 | BMC Endocr Disord | Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients. | 2021 | Details |
| A03423 | 34004366 | Ann Hepatol | NAFLD: Challenges and opportunities to address the public health problem in Latin America. | 2021 | Details |
| A03428 | 34002481 | Kaohsiung J Med Sci | Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study. | 2021 | Details |
| A03430 | 34002452 | Obes Rev | Bariatric surgery and the liver-Mechanisms, benefits, and risks. | 2021 | Details |
| A03431 | 34002333 | Diabetes Ther | Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A03445 | 33996858 | Front Med (Lausanne) | De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study. | 2021 | Details |
| A03451 | 33995271 | Front Endocrinol (Lausanne) | Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis. | 2021 | Details |
| A03452 | 33994867 | Int J Biol Sci | MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03455 | 33994437 | Intern Med | Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03464 | 33992322 | Food Res Int | Long-term supplementation with phenolic compounds from jaboticaba (Plinia jaboticaba (Vell.) Berg) reduces adiposophaty and improves glucose, lipid, and energy metabolism. | 2021 | Details |
| A03465 | 33992031 | Semin Liver Dis | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms. | 2021 | Details |
| A03486 | 33987313 | Ann Transl Med | Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany. | 2021 | Details |
| A03495 | 33983444 | Nephrol Dial Transplant | Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus. | 2022 | Details |
| A03502 | 33979963 | Zhonghua Gan Zang Bing Za Zhi | [Comparative study of clinicopathological features, and risk factors of advanced fibrosis between genders with non-alcoholic fatty liver disease]. | 2021 | Details |
| A03509 | 33977096 | Can J Gastroenterol Hepatol | NAFLD and Infection, a Nuanced Relationship. | 2021 | Details |
| A03511 | 33975804 | Trends Endocrinol Metab | Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A03513 | 33974978 | Free Radic Biol Med | Effects of astaxanthin in animal models of obesity-associated diseases: A systematic review and meta-analysis. | 2021 | Details |
| A03519 | 33972770 | Nat Rev Gastroenterol Hepatol | The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. | 2021 | Details |
| A03520 | 33972568 | Sci Rep | Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway. | 2021 | Details |
| A03527 | 33967948 | Front Endocrinol (Lausanne) | Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population. | 2021 | Details |
| A03554 | 33957975 | BMC Res Notes | Association of 45-bp ins/del polymorphism of uncoupling protein 2 (UCP2) and susceptibility to nonalcoholic fatty liver and type 2 diabetes mellitus in North-west of Iran. | 2021 | Details |
| A03555 | 33957803 | Exp Biol Med (Maywood) | Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. | 2021 | Details |
| A03561 | 33953700 | Front Endocrinol (Lausanne) | Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway. | 2021 | Details |
| A03563 | 33953582 | Diabetes Metab Syndr Obes | Correlation Between 25-Hydroxyvitamin D Level and Cardiac Diastolic Dysfunction in Chinese Adults with Early-Onset Type 2 Diabetes Mellitus: A Cross-Sectional Study. | 2021 | Details |
| A03565 | 33952449 | Anticancer Res | Obesity and Liver Cancer in Japan: A Comprehensive Review. | 2021 | Details |
| A03566 | 33952255 | Lipids Health Dis | Screening for the presence of scleroedema adultorum of Buschke in patients with diabetes mellitus: newly diagnosed patients had a high prevalence of dyslipidaemia. | 2021 | Details |
| A03568 | 33951646 | Dig Dis | Abnormal Liver Blood Tests: Primary Care Approach. | 2021 | Details |
| A03580 | 33946377 | Medicina (Kaunas) | The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on Covid-19 Disease Prognosis. | 2021 | Details |
| A03583 | 33943028 | J Diabetes Investig | Liver fibrosis is independently associated with diabetic peripheral neuropathy in type 2 diabetes mellitus. | 2021 | Details |
| A03585 | 33941551 | BMJ Open Diabetes Res Care | Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1β levels. | 2021 | Details |
| A03593 | 33939118 | Drugs | Targeting AMPK by Statins: A Potential Therapeutic Approach. | 2021 | Details |
| A03604 | 33935282 | Int J Obes (Lond) | The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity. | 2021 | Details |
| A03620 | 33928009 | Clin Nephrol Case Stud | Severe type-B lactic acidosis in a patient with bilateral renal Burkitt's lymphoma. | 2021 | Details |
| A03623 | 33926085 | Genes (Basel) | The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD. | 2021 | Details |
| A03626 | 33925827 | Int J Mol Sci | Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. | 2021 | Details |
| A03629 | 33924909 | Diagnostics (Basel) | Liver Fibrosis and Steatosis in Alström Syndrome: A Genetic Model for Metabolic Syndrome. | 2021 | Details |
| A03633 | 33923817 | Int J Mol Sci | Role of Insulin Resistance in MAFLD. | 2021 | Details |
| A03639 | 33923175 | Cells | Adipocyte, Immune Cells, and miRNA Crosstalk: A Novel Regulator of Metabolic Dysfunction and Obesity. | 2021 | Details |
| A03668 | 33913734 | J Altern Complement Med | Chinese Herbal Medicine Decreases Incidence of Cirrhosis in Patients with Non-Alcoholic Fatty Liver Disease in Taiwan: A Propensity Score-Matched Cohort Study. | 2021 | Details |
| A03674 | 33909947 | Mol Nutr Food Res | Effects of Insoluble Cereal Fibre on Body Fat Distribution in the Optimal Fibre Trial. | 2021 | Details |
| A03677 | 33907839 | Int J Mol Med | Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review). | 2021 | Details |
| A03681 | 33905771 | Clin Gastroenterol Hepatol | A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03699 | 33898961 | JHEP Rep | Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. | 2021 | Details |
| A03700 | 33898960 | JHEP Rep | Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. | 2021 | Details |
| A03704 | 33897616 | Front Endocrinol (Lausanne) | Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis. | 2021 | Details |
| A03716 | 33894145 | Lancet | Non-alcoholic fatty liver disease. | 2021 | Details |
| A03720 | 33893355 | Sci Rep | Liver fat scores do not reflect interventional changes in liver fat content induced by high-protein diets. | 2021 | Details |
| A03721 | 33892409 | Eur J Cancer | Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study. | 2021 | Details |
| A03726 | 33889834 | Metabol Open | Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study. | 2021 | Details |
| A03727 | 33889132 | Front Endocrinol (Lausanne) | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes. | 2021 | Details |
| A03733 | 33885048 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study. | 2021 | Details |
| A03736 | 33883616 | Sci Rep | Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients. | 2021 | Details |
| A03737 | 33883445 | Curr Opin Lipidol | Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides. | 2021 | Details |
| A03740 | 33882758 | Expert Rev Clin Pharmacol | Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease. | 2021 | Details |
| A03745 | 33879970 | J Clin Biochem Nutr | Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study. | 2020 | Details |
| A03748 | 33879084 | BMC Gastroenterol | Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol. | 2021 | Details |
| A03749 | 33878988 | Expert Rev Gastroenterol Hepatol | Liver-spleen axis in nonalcoholic fatty liver disease. | 2021 | Details |
| A03750 | 33878875 | Arch Iran Med | Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening. | 2021 | Details |
| A03753 | 33877366 | Diabetologia | Liver-targeting drugs and their effect on blood glucose and hepatic lipids. | 2021 | Details |
| A03755 | 33876811 | Food Funct | The role of iron homeostasis in adipocyte metabolism. | 2021 | Details |
| A03758 | 33872860 | Mol Metab | Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload. | 2021 | Details |
| A03761 | 33872099 | Scand J Gastroenterol | Etiologies and outcomes of cirrhosis in a large contemporary cohort. | 2021 | Details |
| A03764 | 33871391 | J Chin Med Assoc | Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. | 2021 | Details |
| A03770 | 33869312 | Front Cardiovasc Med | The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases. | 2021 | Details |
| A03785 | 33864798 | Metabolism | Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. | 2021 | Details |
| A03789 | 33862461 | Biochem Biophys Res Commun | Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E2. | 2021 | Details |
| A03794 | 33862045 | Metabolism | Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study. | 2021 | Details |
| A03797 | 33861444 | Adv Exp Med Biol | Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review. | 2021 | Details |
| A03798 | 33861434 | Adv Exp Med Biol | The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. | 2021 | Details |
| A03809 | 33860115 | Hepatol Commun | Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes. | 2020 | Details |
| A03810 | 33860113 | Hepatol Commun | Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes. | 2021 | Details |
| A03819 | 33857552 | Adv Drug Deliv Rev | Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. | 2021 | Details |
| A03850 | 33847462 | Hepatol Res | Meta-analysis of the effect of sodium-glucose cotransporter 2 inhibitors on hepatic fibrosis in patients with type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease. | 2021 | Details |
| A03861 | 33841337 | Front Endocrinol (Lausanne) | Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis. | 2021 | Details |
| A03864 | 33840072 | Curr Obes Rep | The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview. | 2021 | Details |
| A03865 | 33839905 | Eur J Nutr | Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study. | 2021 | Details |
| A03869 | 33838673 | Nutr J | Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial. | 2021 | Details |